Funk, Lucas (Hamburg (govt) 202101 at Innovationsstarter Fonds Hamburg) |
Investment Manager |
Hamburg (govt region) |
Germany |
Funk, Marc (Recipharm 202301 Board Director before since 202103 CEO before 200901–202001 Lonza) |
Chief Executive Officer (CEO) |
Recipharm (Group) |
Sweden |
Funk, Martin (Evomedis 202311 CEO) |
Chief Executive Officer (CEO) |
Evomedis GmbH |
Austria |
Funke, Jonas J. (Plectonic Biotech 202211 CSO + Co-Founder) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Plectonic Biotech (Group) |
Germany |
Furch, Marcus (Rodos BioTarget 200905 CEO) |
Chief Executive Officer (CEO) |
Rodos BioTarget GmbH |
Germany |
Furmanski, Laura (Patient Square Capital 202210 Partner + Head of Patient Square Insights formerly Qiagen 2014–201711) |
Partner (venture partner) |
Patient Square Capital (Group) |
United States (USA) |
Furst, David (Mediq Innovation Experts LLC 201707 Managing Partner befoer LifeSci + GILSC 201109) |
Managing Partner |
Mediq Innovation Experts (Group) |
Israel |
Furuishi, Kazuchika (Showa Denko 202009 Head Minaris Regenerative Medicine business + CEO Minaris LLC |
Chief Executive Officer (CEO) |
Minaris Regenerative Medicine (Group) |
United States (USA) |
Fusek, Jiri (Prague.bio 202402– Managing Director responsible for Prague.bio Conference) |
Managing Director |
Prague.bio, z.s. |
Czech Republic |
Futch, Clarke B. (HealthCare Royalty Partners 201409 founding Managing Director) |
Managing Director |
HealthCare Royalty Partners (HC Royalty) |
United States (USA) |
Füglister, Michael (Cabinet Privé de Conseils 202009) |
Public Relations Manager / Investor Relations Manager |
Cabinet Privé de Conseils S.A. |
Switzerland |
Füller, Stephanie (BioRN Network 202302 Public Relations Manager) |
Public Relations Manager / Investor Relations Manager |
BioRN Network e. V. |
Germany |
Fünfschilling, Hans (früher Roche) |
Governmental Officer (personnel) |
Switzerland (govt) |
Switzerland |
Fürmeier, Sven (Univ Kassel 200908 Institute for Chemistry, Mass Spectrometry) |
Head Mass Spectrometry / NMR Laboratory (university / research institute) |
University of Kassel |
Germany |
Fürstenau-Sharp, Maya (Sartorius 202308 Head of Marketing Cell Culture Technologies) |
Sales Manager / Marketing Manager |
Sartorius (Group) |
Germany |
Fürstenberg-Brock (Deutsche Messe 201009 Projektleiter Biotechnica) |
Event Manager / Conference Manager |
Deutsche Messe AG |
Germany |
Fürstner, Alois (Max Planck 1993– MPI for Coal Research Mühlheim) |
Professor |
Max Planck Society for the Advancement of Science |
|
Fäh, Urban (Bruker Corp 201802 President of Bruker Optics) |
President/Director/Head Business Group/Unit/Division |
Bruker BioSciences (Group) |
|
Färber, Lothar (Climedo Health 202403– advisory board member main org Univ Regensburg formerly at Novartis) |
Advisory Board member |
Climedo Health GmbH |
Germany |
Färber, Nico (Thermo Fisher 201710 Patheon Business Development Executive Pharma Services) |
Business Development Manager / Strategy Manager |
Thermo Fisher (Group) |
Canada |
Fäs, Stefan (BioMedPartners 201702 CFO) |
Chief Financial Officer (CFO) |
BioMedPartners (Group) |
Switzerland |
Fässler, Christoph (Metrohm 201107 CEO) |
Chief Executive Officer (CEO) |
Metrohm (Group) |
Switzerland |
Föger, Florian (Cyprumed 202201 CEO + Founder) |
Chief Executive Officer (CEO) |
Cyprumed GmbH |
Austria |
Föll, Armin (GC biotech 200809) |
n. a. |
GC biotech (Group) |
Germany |
Föller, Andreas (Comites 202102 Managing Director + Founder) |
Managing Director |
Comites GmbH (incl. brand Cardea Life Science) |
Germany |
Förster, Andreas (Dechema 202108 Managing Director) |
Managing Director |
DECHEMA Gesellschaft für Chemische Technik und Biotechnologie e. V. |
Germany |
Förster, Borris (Amathaon Capital 202110 Managing Director + Co-Founder) |
Managing Director |
Amathaon Capital UG (haftungsbeschränkt) |
Germany |
Förster, Hans-Heinrich (Genolytic 201109 Managing Director) |
Managing Director |
Genolytic GmbH |
Germany |
Förtsch, Bernd (BF Holding) |
Managing Director |
BF Holding (Group) |
Germany |
Gaal, Lubor (Targovax 202203– CFO before Locust Walk + Almirall + BMS + Neuro3d + Vectron Therapeutics) |
Chief Financial Officer (CFO) |
Circio (Group) |
Norway |
Gabel, Detlef (Univ Bremen 200911 Prof Organic Chemistry + Kooperationszentrum Medizin) |
Professor |
University of Bremen |
Germany |
Gaber, Faten (Roche 202109 Head of Communications + Public Affairs Roche Pharma) |
Public Relations Manager / Investor Relations Manager |
Roche (Group) |
Germany |
Gabert, Jörg (Priontype 200602 Managing Director) |
Managing Director |
Qiagen (Group) |
Germany |
Gabor, Carolin (Caesar Ventures 202409 Managing Director) |
Managing Partner (investment firm) |
Caesar Ventures Management GmbH (caesar.) |
Germany |
Gabor, E. Allan (Merck (DE) 201801 MAnaging Director + Country Speaker China joined 2013 before Pfizer China) |
Regional manager |
Merck (DE) (Group) |
Germany |
Gabriel, Raimund (MC Services 1999–201101– Founder + CEO) |
Chief Executive Officer (CEO) |
MC Services AG |
Germany |
Gabriel, Sigmar (Germany (govt) 2014 Minister of Economic Affairs and Energy) |
Minister |
Germany (govt) |
Germany |
Gabrielczyk, Thomas |
n. a. |
Biocom (Group) |
Germany |
Gadicke, Ansbert (MPM Capital 201604 Bioventure Investment Manager + Co-Founder) |
Investment Manager |
MPM Capital (Group) |
United States (USA) |
Gadsby, Martin (Optimal Industrial 202204 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Bruker (Group) |
United Kingdom (GB) |
Gahlmann, Reinhold (Biofrontera 200601– Managing Director before 15y Bayer Pharma AG) |
Managing Director |
Biofrontera (Group) |
Germany |
Gaillard, Pierre (Servier 201702 Director of Global Marketing) |
Sales Manager / Marketing Manager |
Servier (Group) |
France |
Gaillard, Pieter J. (to-BBB 200902– CSO before CEO) |
Chief Executive Officer (CEO) |
2-BBB Medicines (Group) |
Netherlands |
Gaissmaier, Christoph (B Braun 201307 Executive Manager) |
Board member, executive |
B. Braun (Group) |
Germany |
Gal, Ronny (Novartis 202408 Chief Strategy + Growth Officer) |
Business Development Manager / Strategy Manager |
Novartis (Group) |
Switzerland |
Galakatos, Nicholas (Clarus Ventures 200906 Managing Director + co-founder) |
Managing Director |
Blackstone (Group) |
United States (USA) |
Galbraith, Daniel (BioOutsource 201402 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Sartorius (Group) |
United Kingdom (GB) |
Galbraith, Susan (AstraZeneca 201212 VP + Head Oncology Innovative Medicines Unit) |
President/Director/Head Business Group/Unit/Division |
AstraZeneca (Group) |
United Kingdom (GB) |
Galdos, Aitor (Tecan 2003–200412 CEO left because of differences over operational management with Board) |
Chief Executive Officer (CEO) |
Tecan (Group) |
Switzerland |
Gale, James (Signet Healthcare Partners 201507 Managing Director) |
Managing Director |
Signet Healthcare Partners (US) |
United States (USA) |
Gales, Ann (A Gales Consulting 201709 Managing Partner) |
Managing Partner |
A Gales Consulting Ltd. |
United Kingdom (GB) |
Galfetti, Paolo (APR Applied Pharma Research 201505 CEO) |
Chief Executive Officer (CEO) |
Relief Therapeutics (Group) |
Switzerland |
Gall, Karsten (Ionovation 201206 Managing Director) |
Managing Director |
Ionovation GmbH |
Germany |
Gallagher, Katie (LaVoieHealthScience 201909) |
Public Relations Manager / Investor Relations Manager |
LaVoieHealthScience (LHS) |
United States (USA) |
Gallagher, Stephen (Steve) (Dotmatics 200612 CEO) |
Chief Executive Officer (CEO) |
Insightful Science (Group) |
United Kingdom (GB) |
Galli, Roberto (Newron 202307– promoted to CFO before VP Finance) |
Chief Financial Officer (CFO) |
Newron (Group) |
Italy |
Galon, Jérôme (INSERM 201507 + Co-Founder of HalioDx) |
Researcher (university / research institute) |
France (govt) |
France |
Galonska, Erez (Infarm 202009 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Infarm – Indoor Urban Farming GmbH |
Germany |
Galuschka, Nicole (MC Services 201705) |
Public Relations Manager / Investor Relations Manager |
MC Services AG |
Germany |
Galushko, Sergey (ChromSword 202108 Owner + Founder) |
Company Founder |
ChromSword (Group) |
Latvia |
Galvin, Robert (Bob) (Bruker Corp 201411 VP Biopharmaceutical Business Unit) |
President/Director/Head Business Group/Unit/Division |
Bruker (Group) |
United States (USA) |
Gamber, Michael (Merck (DE) 201507 Head of Merck Innovation Center) |
n. a. |
Merck (DE) (Group) |
Germany |
Gambillara Fonck, Veronica (Bellevue 202210–Partner at Pureos Partners before GlycoEra + LimmaTech + GlycoVaxyn) |
Managing Director |
Bellevue (Group) |
Switzerland |
Gamer, Jürgen (Apogenix 200810 VP BusDev) |
Business Development Manager / Strategy Manager |
Apogenix AG |
Germany |
Gammack, Jason T. (Ansa Biotechnologies 202402– CEO before Resolve Biosciences + Inscripta + Qiagen + Ingenuity Systems) |
Chief Commercial Officer (CCO) |
Ansa Biotechnologies Inc. |
United States (USA) |
Gammelin, Johann-Caspar (Evonik 202003 Chair Board of Management of Evonik Nutrition + Care) |
President/Director/Head Business Group/Unit/Division |
Evonik (Group) |
Germany |
Ganal, Martin (TraitGenetics GmbH 2000– Managing Director + Founder) |
Managing Director |
SGS (Group) |
Germany |
Ganot, Ilan (Alesta Therapeutics 202501 CEO formerly Solid Biosciences 201509 CEO + Founder) |
Chief Executive Officer (CEO) |
Alesta Therapeutics B.V. |
Netherlands |
Ganten, Detlev |
n. a. |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
Ganyushin, Albert (Euronext 201511 Head of International Listings) |
n. a. |
Euronext (Group) |
Netherlands |
Garaguso, Ignazio (Omnilab 201202 Product Specialist Chromatography Service) |
n. a. |
Omnilab (DE) (Group) |
Germany |
Garaud, Jean-Jacques (Inotrem 201403 CEO before Roche –201206 Global Head pRED) |
President/Director/Head Business Group/Unit/Division |
Inotrem S.A. |
France |
Gardner, Chris (Consilium 201507– Partner before since 2003 at Citigate Dewe Rogerson London) |
Public Relations Manager / Investor Relations Manager |
ICR (Group) |
United Kingdom (GB) |
Gardner, Jason (Magenta Therapeutics 201611 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Dianthus Therapeutics (Group) |
United States (USA) |
Garguilo, Pia (Qiagen 201004– Senior Director Pharma Business Development before AstraZenca LP) |
Business Development Manager / Strategy Manager |
Qiagen (Group) |
Germany |
Garijo, Belén (Merck (DE) 202007– promoted Deputy CEO before CEO of Merck Serono before COO before Sanofi) |
Chief Executive Officer (CEO) |
Merck (DE) (Group) |
Germany |
Garnebode, Nils (Shimadzu 201404 Head Product Support + Marketing at Shimadzu Deutschland Gmb) |
Sales Manager / Marketing Manager |
Shimadzu Deutschland GmbH |
Germany |
Garner, James (Kazia Therapeutics 202004 CEO joined 2016 before Sanofi in Singapore + Bain & Co) |
Chief Executive Officer (CEO) |
Kazia Therapeutics (Group) |
Australia |
Garnier, Jean-Pierre (Pierre Fabre Labs 2008–2010 CEO before GSK 2001–2008 CEO before SmithKline Beecham CEO) |
Chief Executive Officer (CEO) |
GSK (Group) |
United Kingdom (GB) |
Garotti, Alberto (JSR Corp 201801– CFO of Selexis SA before Coty Inc + Unilever) |
Chief Financial Officer (CFO) |
JSR Corporation (Group) |
Switzerland |
Garraway, Levi (Roche 201910– CMO + Head of Global Product Development before Lilly + Harvard + Foundation Medicine) |
Chief Medical Officer (CMO) |
Roche (Group) |
United States (USA) |
Garrett, Dave (Nabriva 201709 Investor Relations) |
Public Relations Manager / Investor Relations Manager |
Nabriva (Group) |
Austria |
Gartenmann, Franzisca (Nemis Technologies 202202 Growth Manager) |
Sales Manager / Marketing Manager |
Nemis Technologies AG |
Switzerland |
Garthoff, Bernward (Nordrhein-Westfalen (govt) 2010 Head of BIO.NRW before Bayer CropScience 200506) |
Business Development Manager / Strategy Manager |
Nordrhein-Westfalen (govt region) |
Germany |
Garzorz-Stark, Natalie (Dermagnostix 202111 Managing Director) |
Managing Director |
Dermagnostix GmbH |
Germany |
Gasche, Nikolaus (Biome Diagnostics 202301 Managing Director + Co-Founder) |
Managing Director |
Biome Diagnostics GmbH |
Austria |
Gasol, Emma (AdBio Partners 202406– promoted to Partner joined 10/23 before Gebro Pharma + Crystax Pharmaceuticals) |
Partner (venture partner) |
AdBio Partners (Group) |
Spain (España) |
Gasper, Roger (MLM Medical Labs 202102– CFO before MaSTherCell + Clinical Supplies Management + JG Wentworth Company) |
Chief Financial Officer (CFO) |
MLM Medical Labs (Group) |
Germany |
Gasser, Kathrin (Kelly Services 202110 Media Spokesperson) |
Public Relations Manager / Investor Relations Manager |
Kelly Services (Group) |
Switzerland |
Gasteiger, Johann (Univ Erlangen-Nuremberg 1994–) |
Company Founder |
University of Erlangen-Nuremberg (Friedrich Alexander University, FAU) |
Germany |
Gatenholm, Erik (Cellink 201908 CEO + Co-Founder RESIGNED as CEO of Bico 11/23 LEFT Board 5/24) |
Chief Executive Officer (CEO) |
Bico (Group) |
Sweden |
Gates, William Henry (Bill), III |
n. a. |
GATES Group (family of Bill Gates) |
United States (USA) |
Gatter, Jochen (AnalytiCon Discovery GmbH 2007) |
n. a. |
BRAIN Biotech (Group) |
Germany |
Gatzemeier, Susanne (Global Fairs 201504) |
n. a. |
Global Fairs (FR) |
France |
Gatzemeyer (Krasnikova), Alexandra (Sartorius 202406 Head of Lab Products + Services divison + Executive Board Member) |
President/Director/Head Business Group/Unit/Division |
Sartorius (Group) |
Germany |
Gauer, Christoph (EliTech Group 202312 CEO before Siemens + Olympus + Advalytix) |
Chief Executive Officer (CEO) |
Elitech (Group) |
France |
Gausepohl, Herr (Intavis 200809) |
Sales Manager / Marketing Manager |
HB Technologies (Group) |
Germany |
Gauthier, Louie-Anne (Oculs 202105 CP Strategic Marketing + BD&L) |
Sales Manager / Marketing Manager |
Oculis (Group) |
Switzerland |
Gavlas, Jozef (Medirex Group 201801 CEO) |
Chief Executive Officer (CEO) |
Medirex Group (CZ/SK) |
Slovak Republic (Slovakia) |
Gawande, Jan-Eric (Aalto Health 202412 Managing Director) |
Managing Director |
Aalto Health GmbH (kaarlo) |
Germany |